Plasma exchange and thrombotic microangiopathies: From pathophysiology to clinical practice

Transfus Apher Sci. 2020 Dec;59(6):102990. doi: 10.1016/j.transci.2020.102990. Epub 2020 Nov 19.

Abstract

Thrombotic microangiopathy (TMA) brings together many diseases that have a commonality in the apparition of mechanical hemolysis with consuming thrombopenia. In all cases, these diseases can be life threatening, thereby justifying the implementation of treatment as an emergency. First-line treatment represents plasma exchange. This treatment has proven efficiency in improving the vital patient's and functional prognosis. However, the administration methods of plasma exchange can be redefined in light of the understanding of the pathophysiology of TMA. The aim of this review is to try to define, from pathophysiology, the place of plasma exchanges in the modern therapeutic arsenal of TMA.

Keywords: Apheresis; Management; Pathophysiology; Plasma exchange; TMA; Thrmbotic microangiopathies.

Publication types

  • Review

MeSH terms

  • Humans
  • Plasma Exchange / methods*
  • Thrombotic Microangiopathies / physiopathology*